Core Viewpoint - The Cannabist Company Holdings Inc. has entered into an agreement to sell its Virginia subsidiary, Green Leaf Medical of Virginia, LLC, for a total consideration of $130 million, following a go-shop process that identified a superior acquisition proposal [1][8]. Transaction Details - The sale involves the purchase of all equity interests of Green Leaf Virginia for $130 million, with $117.5 million payable in cash at closing and $12.5 million held in escrow for post-closing adjustments [3]. - The transaction is subject to certain closing conditions, including regulatory approvals, and is expected to close early in 2026 [4]. Financial Implications - The company plans to use a portion of the net proceeds from the transaction to redeem its Senior Secured Notes [5]. Strategic Review - A special committee of independent directors has been formed to explore strategic alternatives, including asset sales and mergers, in light of ongoing operational and financial challenges [9]. Background Information - The Cannabist Company, formerly known as Columbia Care, operates 77 facilities across 12 U.S. jurisdictions, including 61 dispensaries and 16 cultivation and manufacturing facilities [11].